An Allegheny Health Network research team is among the first to pioneer a treatment for opioid addiction that targets how addiction affects the brain. By using a technique called deep brain stimulation, or DBS, the team hopes to reduce the severe cravings that lead opioid addiction patients to relapse and
Allegheny Health Network (AHN) physicians have joined a landmark clinical trial exploring the safety and efficacy of deep brain stimulation therapy to treat Alzheimer's disease. Led by Donald Whiting, MD, chair of AHN's Neurosciences Institute, Chief Medical Officer for AHN, and a pioneer in the use of DBS to treat a variety of debilitating neurological conditions, the ADvance II Study is an international phase 3 clinical trial being offered only at select medical centers world-wide. - Click here if this is your press release! - eTurboNews | Trends | Travel News